With over 600 million infected worldwide and 95 million in the United States, as of September 2022, the lasting health consequences of the coronavirus disease 2019 (COVID-19) pandemic must be examined. Research has already highlighted several short- and long-term neurologic consequences of COVID-19 including fatigue, headache, memory impairment, and other neurological sequalae. With such a wide-reaching effect, there is a need to continue investigating the development of neurological outcomes among individuals who were infected with COVID-19 to prepare the neurology workforce for a potential increase in patients and proactively identify opportunities to improve health outcomes.